CGEM

Cullinan Oncology (CGEM)

About Cullinan Oncology (CGEM)

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Details

Daily high
$9.93
Daily low
$9.47
Price at open
$9.58
52 Week High
$30.19
52 Week Low
$9.47
Market cap
554.9M
Dividend yield
0.00%
Volume
280,816
Avg. volume
430,527
P/E ratio
-3.31

Cullinan Oncology News

Details

Daily high
$9.93
Daily low
$9.47
Price at open
$9.58
52 Week High
$30.19
52 Week Low
$9.47
Market cap
554.9M
Dividend yield
0.00%
Volume
280,816
Avg. volume
430,527
P/E ratio
-3.31